Robert Driscoll: We See Substantial Synergies Between Both Cidara and Mundipharma Given Mundipharma Already has a Significant Global Commercial Reach with Annual Sales Over €2B - Wedbush Securities

Robert Driscoll: We See Substantial Synergies Between Both Cidara and Mundipharma Given Mundipharma Already has a Significant Global Commercial Reach with Annual Sales Over €2B

09.04.2019

For more on Robert Driscoll’s comments: Wedbush Recommends Buying Cidara Shares After Rezafungin Deal